These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2755275)

  • 1. Study on the peroral absorption of the endekapeptide cyclosporine A.
    Ritschel WA; Ritschel GB; Sabouni A; Wolochuk D; Schroeder T
    Methods Find Exp Clin Pharmacol; 1989 Apr; 11(4):281-7. PubMed ID: 2755275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of peroral absorption of cyclosporine A by microemulsions.
    Ritschel WA; Adolph S; Ritschel GB; Schroeder T
    Methods Find Exp Clin Pharmacol; 1990 Mar; 12(2):127-34. PubMed ID: 2319836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preparation and evaluation of a tablet dosage form of cyclosporine in dogs.
    Abdallah HY; Mayersohn M
    Pharm Res; 1991 Apr; 8(4):518-22. PubMed ID: 1871050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability assessment of cyclosporine in the rat. Influence of route of administration.
    Luke DR; Brunner LJ; Vadiei K
    Drug Metab Dispos; 1990; 18(2):158-62. PubMed ID: 1971566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral.
    Ritschel WA
    Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meperidine pharmacokinetics following intravenous, peroral and buccal administration in beagle dogs.
    Ritschel WA; Neub M; Denson DD
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):811-5. PubMed ID: 3441166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.
    Steffan J; Strehlau G; Maurer M; Rohlfs A
    J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of tablets and capsules containing spray-dried o/w-emulsions for oral delivery of poorly soluble drugs.
    Hansen T; Holm P; Rohde M; Schultz K
    Int J Pharm; 2005 Apr; 293(1-2):203-11. PubMed ID: 15778058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the application form of cyclosporine on blood levels: comparison of oral solution and capsules.
    Nashan B; Bleck J; Wonigeit K; Vogt P; Christians U; Sewing KF; Beveridge T; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):637-9. PubMed ID: 3284113
    [No Abstract]   [Full Text] [Related]  

  • 12. Absolute and relative bioavailability of lithium dosage forms in the beagle dog.
    Banarer M; Ritschel WA
    Arzneimittelforschung; 1982; 32(4):383-8. PubMed ID: 6896645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioavailability of papaverine HCl after intravenous, intracorporeal and penis topical administration in beagle dogs.
    Shaaya AN; Kraus C; Bauman DH; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1992 Jun; 14(5):373-8. PubMed ID: 1513193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and pharmacokinetic studies in the development of an oral formulation of stobadine dipalmitate.
    Bauerová K; Bohov P; Durisová M; Bezek S
    Methods Find Exp Clin Pharmacol; 1999 Sep; 21(7):499-503. PubMed ID: 10544395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the bioavailability of different formulations of 8-methoxypsoralen in the dog.
    Monbaliu JG; Belpaire FM; Bogaert MG
    Biopharm Drug Dispos; 1988; 9(1):1-8. PubMed ID: 3342281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the immune system on cyclosporine absorption.
    Luke DR
    Xenobiotica; 1991 Jun; 21(6):817-24. PubMed ID: 1949911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of three formulations of diphenylhydantoin in the dog.
    Overduin LM; van Gogh H; Mol JA; van Nes JJ
    Res Vet Sci; 1989 Mar; 46(2):271-3. PubMed ID: 2704892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion.
    Peng B; Dutreix C; Mehring G; Hayes MJ; Ben-Am M; Seiberling M; Pokorny R; Capdeville R; Lloyd P
    J Clin Pharmacol; 2004 Feb; 44(2):158-62. PubMed ID: 14747424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient.
    Hirunpanich V; Sato H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):247-52. PubMed ID: 19560537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.